Kelly T. McKee's Insider Trades & SAST Disclosures

Kelly T. McKee's most recent trade in Geovax Labs Inc was a trade of 15,700 Stock Option done . Disclosure was reported to the exchange on Aug. 12, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Geovax Labs Inc
Kelly T. McKee Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 15,700 15,700 - - Stock Option
Geovax Labs Inc
McKee Kelly T. Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 0.36 per share. 22 Dec 2023 6,944 35,782 - 0.4 2,500 Common Stock
Geovax Labs Inc
Kelly T. McKee Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2023 15,000 15,000 - - Stock Option
Geovax Labs Inc
Kelly T. McKee Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 1.12 per share. 27 Jun 2022 4,464 19,185 - 1.1 5,000 Common Stock
Geovax Labs Inc
Kelly T. McKee Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 0.72 per share. 05 May 2022 9,722 14,721 - 0.7 7,000 Common Stock
Geovax Labs Inc
Kelly T. McKee Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 0.71 per share. 04 May 2022 4,999 4,999 - 0.7 3,549 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades